Contineum Therapeutics Inc. Class A (CTNM)
NASDAQ: CTNMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 12.73 0.00%
CTNM stock chart
Technical analysisKey statistics
All statistics- Market cap
- $478.92M
- EPS (TTM)
- -$1.73
- Dividend yield
- None
- 52-week range
- 8.60 – 17.79
- Day range
- 12.31 – 13.01
- Volume / Avg
- 707.73K / 501.08K
- Beta
- —
- Shares outstanding
- 32.96M
- Next earnings
- Oct 29, 2026
52-week range
CTNM stock today
On Oct 7, CTNM ended the session at $12.73, adding $0.08 (0.63%), versus the S&P 500's 0.22% decline. At this level, CTNM sits in the middle of its 52-week range of $8.60 to $17.79: 28.4% below the high, set on Sep 3, 2026 and 48.0% above the low. CTNM is up 11.4% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 11.8%.
Contineum Therapeutics has posted a net loss over the last twelve months (EPS of -$1.73), so its P/E ratio is not meaningful. Contineum Therapeutics's next earnings report is expected on Oct 29, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Contineum Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2024
Earnings
Earnings history- Next report
- Oct 29, 2026
- EPS estimate
- $-0.45
CTNM news
All CTNM newsContineum Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ARVNArvinas Inc. | 7.45 | +1.92% | $480.68M | vs CTNM |
| CAPRCapricor Therapeutics Inc. | 8.10 | +4.52% | $470.93M | vs CTNM |
| ASMBAssembly Biosciences Inc. | 22.95 | +3.47% | $467.28M | vs CTNM |
| OVIDOvid Therapeutics Inc. | 2.36 | -0.42% | $460.90M | vs CTNM |
| KMDAKamada Ltd. | 7.89 | -2.71% | $455.33M | vs CTNM |
| ACRSAclaris Therapeutics Inc. | 3.40 | -8.11% | $500.48M | vs CTNM |
| CBIOCrescent Biopharma Inc. | 13.49 | -0.59% | $501.11M | vs CTNM |
| PBYIPuma Biotechnology Inc | 9.81 | +3.26% | $506.39M | vs CTNM |
Indexes, lists and sector
Largest Health Care stocks
Contineum Therapeutics stock FAQ
What is Contineum Therapeutics's stock price today?
CTNM last traded at $12.73 as of Oct 7, 4:00 PM EDT, up 0.63% on the day. Prices are delayed at least 15 minutes.
When is Contineum Therapeutics's next earnings date?
Contineum Therapeutics is expected to report earnings on Thursday, October 29, 2026. Analysts expect EPS of $-0.45.
What is the CTNM 52-week high?
The 52-week high for CTNM is $17.79 and the 52-week low is $8.60. The stock is currently 28.4% below its high.